Archive for December, 2007

Humira, a biologic treatment already approved in the U.S. and Europe for psoriatic arthritis, has been approved by European regulators for moderate to severe psoriasis. It is expected to receive U.S. Food and Drug Administration approval as a psoriasis treatment in the near future.

Psoriasis Cure Now, a nonprofit patient advocacy group, responded to a startling new study showing an association between severe psoriasis and a significantly increased risk of death, by renewing calls for more psoriasis research. The study, by a team of University of Pennsylvania School of Medicine researchers, found patients with severe psoriasis have a 50%
READ THE FULL POST

Centocor has filed an application with the U.S. Food and Drug Administration (FDA) seeking approval of its experimental treatment ustekinumab (previously known as CNTO 1275) for the treatment of adult patients with chronic moderate to severe plaque psoriasis. Centocor’s Biologics License Application (BLA) submission means that FDA approval of ustekinumab for psoriasis could come
READ THE FULL POST